We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
DELISTED
Janus Henderson
JHG
| $97K | ﹤0.01% |
2,730
+1,242
| +83% | +$44.7K |
2019 Q2
11 quarters
|
|
1002
Suncor Energy
SU
$91.3B
| $97K | ﹤0.01% |
2,929
+187
| +7% | +$5.55K |
2016 Q4
21 quarters
|
|
1003
Defiance Space and Connective Tech ETF
UFOX
$807M
| $97K | ﹤0.01% |
2,529
+4
| +0.2% | +$152 |
2019 Q3
10 quarters
|
|
1004
News Corp Class A
NWSA
$16.2B
| $96K | ﹤0.01% |
4,224
-93
| -2% | -$2.06K |
2016 Q4
21 quarters
|
|
1005
Range Resources
RRC
$10.1B
| $96K | ﹤0.01% |
3,131
+5
| +0.2% | +$114 |
2016 Q4
21 quarters
|
|
1006
ARK Blockchain & Fintech Innovation ETF
ARKF
$878M
| $95K | ﹤0.01% |
3,117
-6,002
| -66% | -$185K |
2020 Q3
6 quarters
|
|
1007
BioMarin Pharmaceuticals
BMRN
$10.6B
| $95K | ﹤0.01% |
1,215
-262
| -18% | -$21.9K |
2016 Q4
21 quarters
|
|
1008
Ingles Markets
IMKTA
$1.64B
| $95K | ﹤0.01% |
1,051
+8
| +0.8% | +$680 |
2016 Q4
21 quarters
|
|
1009
James Hardie Industries
JHX
$15B
| $95K | ﹤0.01% |
3,013
-618
| -17% | -$21K |
2016 Q4
21 quarters
|
|
1010
VanEck Agribusiness ETF
MOO
$1.14B
| $95K | ﹤0.01% |
900
-1,899
| -68% | -$184K |
2016 Q4
21 quarters
|
|
1011
DELISTED
Orange
ORAN
| $95K | ﹤0.01% |
7,923
+5,445
| +220% | +$63.6K |
2016 Q4
21 quarters
|
|
1012
Celanese
CE
$5.21B
| $94K | ﹤0.01% |
651
-378
| -37% | -$57.7K |
2016 Q4
21 quarters
|
|
1013
Hyperfine
HYPR
$80M
| $94K | ﹤0.01% |
27,326
| – | – |
2021 Q4
1 quarter
|
|
1014
JPMorgan Equity Premium Income ETF
JEPI
$45.8B
| $94K | ﹤0.01% |
1,525
| – | – |
2021 Q3
2 quarters
|
|
1015
Nektar Therapeutics
NKTR
$1.22B
| $94K | ﹤0.01% |
1,130
-38
| -3% | -$5.62K |
2018 Q1
16 quarters
|
|
1016
Companhia Siderúrgica Nacional
SID
$1.47B
| $94K | ﹤0.01% |
16,974
-4,030
| -19% | -$20K |
2018 Q3
14 quarters
|
|
1017
Telkom Indonesia
TLK
$10.9B
| $94K | ﹤0.01% |
2,897
-105
| -3% | -$3.19K |
2016 Q4
21 quarters
|
|
1018
Unum
UNM
$14.6B
| $94K | ﹤0.01% |
2,991
-183
| -6% | -$5.11K |
2016 Q4
21 quarters
|
|
1019
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$18.9B
| $94K | ﹤0.01% |
417
-36
| -8% | -$7.95K |
2021 Q1
4 quarters
|
|
1020
argenx
ARGX
$51.5B
| $93K | ﹤0.01% |
296
-87
| -23% | -$25.3K |
2020 Q3
6 quarters
|
|
1021
Invesco DB Commodity Index Tracking Fund
DBC
$2B
| $93K | ﹤0.01% |
3,502
| – | – |
2016 Q4
21 quarters
|
|
1022
Raymond James Financial
RJF
$30.2B
| $93K | ﹤0.01% |
829
+68
| +9% | +$7.2K |
2016 Q4
21 quarters
|
|
1023
CryoPort
CYRX
$853M
| $92K | ﹤0.01% |
2,638
-25
| -0.9% | -$945 |
2021 Q4
1 quarter
|
|
1024
CenterPoint Energy
CNP
$26.7B
| $91K | ﹤0.01% |
2,945
-497
| -14% | -$14K |
2016 Q4
21 quarters
|
|
1025
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.2B
| $91K | ﹤0.01% |
6,481
+1,481
| +30% | +$20.7K |
2020 Q1
8 quarters
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.